secwatch.observer — SEC 8-K summary
======================================

Issuer:     CITIUS ONCOLOGY, INC. (CTOR)
CIK:        0001851484
Form:       8-K
Filed at:   2025-07-18T23:59:59+00:00
Accession:  0001213900-25-065334
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Citius Oncology closes $9.0M public offering of 6.82M shares & warrants
-----------------------------------------------------------------------

- Priced 6,818,182 units at $1.32 each, each consisting of 1 share + 1 warrant for 1 common share.
- Gross proceeds ~$9.0M; net proceeds ~$7.44M after placement agent fees and expenses.
- Warrants exercisable at $1.32/share, immediately exercisable, expire 5 years from issuance.
- Proceeds to support LYMPHIR commercialization, milestone/royalty payments, and working capital.
- Placement agent Maxim Group LLC; 45-day lock-up on new share issuance after closing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1851484/000121390025065334/0001213900-25-065334-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1851484/000121390025065334/ea0249292-8k_citius.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-065334

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer